Epitope landscape in autoimmune neurological disease and beyond

I Talucci, HM Maric - Trends in Pharmacological Sciences, 2024 - cell.com
Autoantibody binding has a central role in autoimmune diseases and has also been linked
to cancer, infections, and behavioral disorders. Autoimmune neurological diseases remain …

NMOSD and MOGAD

E Sechi - CONTINUUM: Lifelong Learning in Neurology, 2024 - journals.lww.com
OBJECTIVE This article reviews the clinical features, MRI characteristics, diagnosis, and
treatment of aquaporin-4 antibody–positive neuromyelitis optica spectrum disorder (AQP4 …

Time to treat first acute attack of myelin oligodendrocyte glycoprotein antibody-associated disease

YN Kwon, B Kim, JS Kim, KS Park, DY Seo… - JAMA …, 2024 - jamanetwork.com
Importance A proportion of people with myelin oligodendrocyte glycoprotein antibody-
associated disease (MOGAD) have a relapsing disease course and persistent anti–myelin …

[HTML][HTML] MOGAD: A comprehensive review of clinicoradiological features, therapy and outcomes in 4699 patients globally

BP Trewin, F Brilot, SW Reddel, RC Dale… - Autoimmunity …, 2024 - Elsevier
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is one of the
most common antibody-mediated CNS disorders. Optimal diagnostic and prognostic …

MOG antibody-associated optic neuritis

N Jeyakumar, M Lerch, RC Dale, S Ramanathan - Eye, 2024 - nature.com
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is a
demyelinating disorder, distinct from multiple sclerosis (MS) and neuromyelitis optica …

[PDF][PDF] Brain health–time matters

H Butzkueven, G Giovannoni, S Arkelsten, G Comi… - 2024 - msbrainhealth.org
Oxford Health Policy Forum CIC is a not-for-profit community interest company registered in
England and Wales (registration number: 10475240). Oxford Health Policy Forum CIC is …

MYELIN OLIGODENDROCYTE ANTIBODY ASSOCIATED DISEASE (MOGAD): A REVIEW OF MECHANISMS, CLINICAL FEATURES, PATHOLOGY, AND NEW …

F Abraham - 2024 - repository.arizona.edu
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) was
defined as a neuroimmune disorder of the central nervous system in 2007. In recent years …

Myelin-Oligodendrozyten-Glykoprotein-Antikörper-assoziierte Erkrankungen

A Winkelmann, P Rommer, M Hecker, UK Zettl - DGNeurologie, 2024 - Springer
Untersuchungen aus mehreren Ländern legen die Vermutung nahe, dass MOGAD eine
globale Erkrankung ist und Menschen aller Altersgruppen betreffen kann. Die Inzidenz von …